--2025/Q1-- / 151.330K--
--2024/Q4-- / 232.760K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
May 15, 20242024/Q1325.000K / 68.800K--
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 3.1350
- -3.0350-49.19%
Trading Nov 21 14:00 ET
211.89MMarket Cap-2104P/E (TTM)
4.5900High3.0600Low9.13MVolume4.5100Open6.1700Pre Close31.00MTurnover20.41%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.65P/B140.23MFloat Cap2.280052wk Low--Dividend TTM44.73MShs Float85.0000Historical High--Div YieldTTM24.80%Amplitude0.0300Historical Low3.3960Avg Price1Lot Size
Perspective Therapeutics Key Stats
Perspective Therapeutics Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 237.91K | 0 | -237.91K |
| Miss Est. | -87.54% | -- | -100.00% |
| EPS | -0.21 | -0.21 | +<0.01 |
| Beat Est. | +46.29% | +43.24% | +2.23% |
Analyst Rating
Nov 13, 2024
Perspective Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Perspective Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data